《Pulmonary Pharmacology & Therapeutics》是一本由ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD出版商出版的专业医学期刊，该刊创刊于1997年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：药学 3区；呼吸系统 3区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.282，平均审稿速度较慢,6-12周。

Pulmonary Pharmacology & Therapeutics英文介绍

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.

Research Areas Include:

? All major diseases of the lung

? Physiology

? Pathology

? Drug delivery

? Metabolism

? Pulmonary Toxicology.

Pulmonary Pharmacology & Therapeutics中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	PHARMACOLOGY & PHARMACY 药学 RESPIRATORY SYSTEM 呼吸系统	3区 3区	否	否

Pulmonary Pharmacology & Therapeutics期刊近9年JCR分区变化趋势

Pulmonary Pharmacology & TherapeuticsJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q3	PHARMACOLOGY & PHARMACY	Q3	3.282
Q3	RESPIRATORY SYSTEM	Q3	3.282

Pulmonary Pharmacology & Therapeutics期刊近7年影响因子变化趋势

Pulmonary Pharmacology & Therapeutics期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
5.80	0.671	0.844	大类：Medicine 小类：Pulmonary and Respiratory Medicine	Q1	31 / 140	78%
			大类：Medicine 小类：Pharmacology (medical)	Q1	63 / 255	75%
			大类：Medicine 小类：Biochemistry (medical)	Q2	22 / 61	64%

Pulmonary Pharmacology & Therapeutics期刊近7年自引率变化趋势

上周TOP10